Syon Capital LLC Has $3.73 Million Stock Position in SPDR S&P Biotech ETF $XBI

Syon Capital LLC raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 67.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,562 shares of the exchange traded fund’s stock after purchasing an additional 9,530 shares during the quarter. Syon Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $3,729,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Axiom Investment Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $26,000. Financial Life Planners acquired a new position in SPDR S&P Biotech ETF in the first quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in SPDR S&P Biotech ETF in the fourth quarter worth approximately $27,000. Intesa Sanpaolo Wealth Management bought a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $30,000. Finally, SHP Wealth Management bought a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $31,000.

SPDR S&P Biotech ETF Stock Down 0.6%

NYSEARCA XBI opened at $164.38 on Friday. The stock has a market capitalization of $10.73 billion, a PE ratio of 11.47 and a beta of 0.84. The company has a 50 day moving average price of $158.01 and a two-hundred day moving average price of $140.34. SPDR S&P Biotech ETF has a 12-month low of $92.49 and a 12-month high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.